Bitcoin groundbreakers share personal stories of how Bitcoin is changing lives for the better. Host Mauricio Di Bartolomeo, co-founder and CSO of Ledn, speaks with leading Bitcoin voices, entrepreneurs, and human rights advocates to hear their unique journey and practical real-world examples of how Bitcoin has made a positive impact in their lives. Brought to you by Ledn, a leading financial services company built for Bitcoin & digital assets. Ledn offers a suite of lending, saving and tradi ...
…
continue reading
Вміст надано Proactive Investors. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією Proactive Investors або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
Player FM - додаток Podcast
Переходьте в офлайн за допомогою програми Player FM !
Переходьте в офлайн за допомогою програми Player FM !
Healthcare outlook 2025: healthcare and biotech to regain investor focus
MP3•Головна епізоду
Manage episode 461207170 series 2891889
Вміст надано Proactive Investors. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією Proactive Investors або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
The healthcare and biotech sectors are set to regain investor interest in 2024 due to long-term growth prospects, aided by structural drivers such as ageing populations and rising healthcare expenditure. Healthcare now contributes 10.2% of global GDP, with annual spending expected to reach $14 trillion by 2030. Previously overshadowed by technology, healthcare is now viewed as undervalued following small-cap underperformance last year. Anteris Technologies Global Corp (ASX:AVR, OTC:AMEUF) is advancing its DurAVR® Transcatheter Heart Valve to treat severe aortic stenosis, supported by an $88.8 million Nasdaq IPO to fund further development and clinical trials. Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) is focused on synthetic anti-infectives targeting antibiotic-resistant bacteria and viral infections. Its flagship candidate, RECCE® 327, has received approval for a Phase 3 trial in Indonesia for diabetic foot infections, opening commercial avenues in the ASEAN region. Tryptamine Therapeutics Ltd (ASX:TYP, OTC:TYPTF) develops psilocin-based treatments for neuropsychiatric disorders. Interim results from a Phase 2A trial show potential for addressing Irritable Bowel Syndrome. Orthocell Ltd (ASX:OCC, OTC:ORHHF) targets regenerative medicine, with approved products such as Remplir™ for nerve repair and Striate Plus™ for dental applications. The company aims to expand into the US and other global markets. Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) specialises in rapid diagnostic tests. Its products, FebriDx® and ViraDx™, have received FDA approval, with ongoing efforts to expand within women’s health diagnostics. #HealthcareSector #Biotech #MedicalDevices #DrugDevelopment #RegenerativeMedicine #Diagnostics #BiotechInvesting #GlobalGDP #AorticStenosis #AntibioticResistance #Superbugs #PsilocybinResearch #ChronicPain #NerveRepair #DentalRegeneration #RapidDiagnostics #COVIDTesting #FluTesting #HealthcareInnovation #InvestorOutlook
…
continue reading
615 епізодів
MP3•Головна епізоду
Manage episode 461207170 series 2891889
Вміст надано Proactive Investors. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією Proactive Investors або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
The healthcare and biotech sectors are set to regain investor interest in 2024 due to long-term growth prospects, aided by structural drivers such as ageing populations and rising healthcare expenditure. Healthcare now contributes 10.2% of global GDP, with annual spending expected to reach $14 trillion by 2030. Previously overshadowed by technology, healthcare is now viewed as undervalued following small-cap underperformance last year. Anteris Technologies Global Corp (ASX:AVR, OTC:AMEUF) is advancing its DurAVR® Transcatheter Heart Valve to treat severe aortic stenosis, supported by an $88.8 million Nasdaq IPO to fund further development and clinical trials. Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) is focused on synthetic anti-infectives targeting antibiotic-resistant bacteria and viral infections. Its flagship candidate, RECCE® 327, has received approval for a Phase 3 trial in Indonesia for diabetic foot infections, opening commercial avenues in the ASEAN region. Tryptamine Therapeutics Ltd (ASX:TYP, OTC:TYPTF) develops psilocin-based treatments for neuropsychiatric disorders. Interim results from a Phase 2A trial show potential for addressing Irritable Bowel Syndrome. Orthocell Ltd (ASX:OCC, OTC:ORHHF) targets regenerative medicine, with approved products such as Remplir™ for nerve repair and Striate Plus™ for dental applications. The company aims to expand into the US and other global markets. Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) specialises in rapid diagnostic tests. Its products, FebriDx® and ViraDx™, have received FDA approval, with ongoing efforts to expand within women’s health diagnostics. #HealthcareSector #Biotech #MedicalDevices #DrugDevelopment #RegenerativeMedicine #Diagnostics #BiotechInvesting #GlobalGDP #AorticStenosis #AntibioticResistance #Superbugs #PsilocybinResearch #ChronicPain #NerveRepair #DentalRegeneration #RapidDiagnostics #COVIDTesting #FluTesting #HealthcareInnovation #InvestorOutlook
…
continue reading
615 епізодів
كل الحلقات
×Ласкаво просимо до Player FM!
Player FM сканує Інтернет для отримання високоякісних подкастів, щоб ви могли насолоджуватися ними зараз. Це найкращий додаток для подкастів, який працює на Android, iPhone і веб-сторінці. Реєстрація для синхронізації підписок між пристроями.